A9542 In111 ibritumomab, dx

Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 1 units per day (practitioner), rationale: Code Descriptor / CPT Instruction